Tue, Aug 20 9:54am

Compare NVO

Novo Nordisk A/S Common Stock [NVO]
$51.30 0.08 (0.16%)

NVO Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 122.40 Billion
NVO Description

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, as well as oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Visit Website

NVO Earnings

EPS 4.03 P/E Ratio 18.42
Previous Earnings Fri, Aug 9, 2019
Latest Earnings Fri, Nov 1, 2019 (In 73 days)

NVO Dividend

Yield 3.08% / $1.58
Ex-Date Fri, Mar 22, 2019 (151 days ago)
Pay Date Tue, Apr 2, 2019
History 38 Payments (Biannual)

NVO Charts

1 Year
Oct 11, 2018
Mar 20, 2019

Symbol Price Day % YTD %
NVO $51.30 0.16% 9.55%

Symbol Surfing

How can we make Symbol Surfing better?


Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy